VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH MM 2018 | How do we define a ‘cure’ in myeloma?

How to we define a ‘cure’ in multiple myeloma (MM)? We spoke to Annemiek Broyl, MD, PhD, of Erasmus Medical Center and University, Rotterdam, Netherlands, about this important and interesting topic, as well as the role of measurable residual disease (MRD) in this definition, at the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter